Our Sponsoring Partners
The Lp(a)-Update 2026 is made possible through the support of numerous sponsors. We would like to thank all companies whose sponsorship contributes to the organization of the congress and supports professional exchange on the risk factor lipoprotein(a).
The following companies support the Lp(a)-Update 2026:
 |
 |
|
 |
 |
|
 |
 |
|
 |
 |
|
 |
 |
|
 |
 |
|
 |
 |
The organizer of the scientific congress program is the
|
Deutsche Gesellschaft für |
If you have any questions, please contact the appointed agency at lpa-update@kwhc.de.
The event is sponsored by the following companies:
Novo Nordisk Pharma GmbH (14.169,40 €), Lilly Deutschland GmbH (10.000,00 €), Sanofi-Aventis Deutschland GmbH (8.500,00 €), Amgen GmbH (7.754,10 €), Kaneka Medical Europe N.V. (7.559,20 €), DIAMED Medizintechnik GmbH (6.169,40 €), Fresenius Medical Care GmbH (6.169,40 €), Medica GmbH (6.169,40 €), Novartis Pharma GmbH (4.969,40), B. Braun Deutschland GmbH & Co. KG (4.169,40 €), Breu GmbH (4.169,40 €), Chiesi GmbH (4.169,40 €), Meise Medizintechnik GmbH (4.169,40 €), Swedish Orphan Biovitrum GmbH (4.169,40 €).
The total expenditure for the event amounts to approximately € 95.000.
The content of this event is designed to be product- and service-neutral, and the sponsors have no influence on the selection of topics, speakers, content, or presentation formats. We confirm that the scientific leadership and the speakers disclose any potential conflicts of interest to the participants.